MedTrace Logo

Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1c

NCT00445354 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2019-02-07

No results posted yet for this study

Summary

This study will randomize diabetics with hemoglobin A1c greater than 7.0 to receive either cinnamon plus usual care or usual care alone. Hemoglobin A1c will be measured at intake and after 90 days.

Conditions

Interventions

DRUG

cinnamon

Sponsors & Collaborators

  • Eglin AFB Regional Hospital

    lead FED

Principal Investigators

  • Paul F Crawford, MD · Eglin AFB Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00445354 on ClinicalTrials.gov